Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction.

Oehler, Vivian G

Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction. [electronic resource] - Current hematologic malignancy reports Sep 2006 - 152-9 p. digital

Publication Type: Journal Article; Review

1558-822X

10.1007/s11899-996-0003-x doi


Adult
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Benzamides
Biomarkers, Tumor--blood
Bone Marrow Transplantation--methods
Child
Clinical Trials as Topic
Combined Modality Therapy
Disease-Free Survival
Drug Monitoring
Drug Resistance, Neoplasm--genetics
Fusion Proteins, bcr-abl--antagonists & inhibitors
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Multicenter Studies as Topic
Neoplasm, Residual
Piperazines--administration & dosage
Polymerase Chain Reaction--methods
Protein Kinase Inhibitors--administration & dosage
Pyrimidines--administration & dosage
Recurrence
Sensitivity and Specificity